Spironolactone use was associated with 12% decreased odds of prostate cancer in male patients and 19% decreased odds of bladder cancer in female patients.
Mean levels of total serum testosterone and serum dihydrotestosterone were significantly higher in urolithiasis cases compared with controls.
Partial and radical nephrectomy were associated with similar cancer-specific and overall survival in elderly patients.
For every 1 mm increase in stone size, the odds of passage increased by 9.8%.
HIV-infected men and women had lower incidences of colorectal and lung cancer compared with the general population.
Updated label for patiromer now recommends the drug be taken at least 3 hours before or after other oral medications.